Hasnyálmirigyrák: vizsgálatok itt: Németország
53 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Berlin, Düsseldorf, Freiburg im Breisgau, München, Würzburg
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 3. fázisTaking peopleAtebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Hamburg, Heilbronn, Muenchen, Munich, Riesa
- Életkor
- 18 év and over
- People
- 570 worldwide
- Run by
- Immuneering Corporation
See details and how to joinNCT07562152 · EU 2026-525617-31-00 - 1. fázisTaking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Essen
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Hamburg, Heidelberg, Leipzig, Mainz, München, Würzburg
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 3. fázisTaking peopleA Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Where
- Aachen, Bad Saarow, Berlin, Bochum, Dresden, Duesseldorf, Frankfurt am Main, Hamburg, Hanover, Leipzig, Magdeburg, Mainz, Mannheim, Muenster, Munich, Regensburg, Saarbruecken, Ulm, Wuerzburg
- Életkor
- 18 év and over
- People
- 614 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07409272 · EU 2025-523684-38-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Berlin, Erlangen, Essen, Mainz, Marburg, Tübingen, Würzburg
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 3. fázisTaking peopleA Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Berlin, Bochum, Bonn, Cologne, Dresden, Düsseldorf, Essen, Frankfurt, Freiburg im Breisgau, Göttingen, Halle, Hamburg, Leipzig, München, Munich, Nuremberg, Ulm
- Életkor
- 18 év and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073 - No phaseTaking peoplePancreatic Cancer Early Detection Consortium
- Where
- Essen
- Életkor
- 18 év to 90 év
- People
- 20 000 worldwide
- Run by
- Arbor Research Collaborative for Health
See details and how to joinNCT04970056 - 1/2. fázisTaking peopleBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Bonn, Ulm
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Frankfurt
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Berlin, Dresden, Heidelberg, Heilbronn, Leipzig, Mainz, Muenster
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 3. fázisTaking peopleStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Berlin, Frankfurt am Main, Heidelberg, Luebeck, Munich, Ulm
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07252232 · EU 2025-523495-23-00 - 3. fázisTaking peopleA study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma
- Where
- Aachen, Augsburg, Berlin, Bochum, Bonn, Cologne, Deggendorf, Dresden, Erlangen, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Halle Saale, Hamburg, Hanover, Heidelberg, Homburg, Jena, Kiel, Leipzig, Luebeck, Mainz, Mannheim, Marburg, Munich, Paderborn, Regensburg, Rostock, Saarbruecken, Ulm, Winnenden, Wuerzburg
- Életkor
- 18 év and over
- People
- 414 worldwide
- Run by
- Universitaetsklinikum Heidelberg AöR
See details and how to joinNCT05314998 · EU 2024-514682-19-00 - 3. fázisNot yet taking people in NémetországPhase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Berlin, Bochum, Dresden, Frankfurt am Main, Hamburg, Munich, Ulm
- Életkor
- 18 év and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00 · EU 2025-524969-24-00 - 1/2. fázisTaking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Bochum, Düsseldorf, Frankfurt am Main, Lübeck, München
- Életkor
- 18 év and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - 2/3. fázisNot yet taking people in NémetországA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Dresden, Essen, Hamburg, Ulm
- Életkor
- 18 év and over
- People
- 194 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-522563-15-00 · EU 2025-522563-15-00 - 1/2. fázisTaking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Bochum, München, Ulm
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - 1. fázisTaking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Berlin, Ulm, Wuerzburg
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - 2/3. fázisTaking peopleA Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Berlin, Dresden, Düsseldorf, Leipzig, München
- Életkor
- 18 év and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Essen
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Bayern, Berlin, Heidelberg, Mainz
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - 3. fázisTaking peopleStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Berlin, Bochum, Bonn, Dresden, Frankfurt am Main, Heidelberg, München, Tuebingen, Ulm, Wuerzburg
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Magdeburg
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - 1/2. fázisTaking peoplePhase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
- Where
- Berlin, Bochum, Dresden, Frankfurt am Main, Leipzig, Mainz
- Életkor
- 18 év and over
- People
- 26 worldwide
- Run by
- Merck Healthcare KGaA
See details and how to join2024-517819-74-00 · EU 2024-517819-74-00 - 2. fázisTaking peopleUsing lab-grown mini-tumors from pancreatic cancer tissue to predict and improve post-surgery treatment for pancreatic cancer
- Where
- Berlin, Bochum, Mannheim, Munich, Nuremberg, Tuebingen, Ulm
- Életkor
- 18 év and over
- People
- 92
- Run by
- Universitaetsklinikum Ulm AöR
See details and how to join2023-510490-34-00 · EU 2023-510490-34-00